AllSight
Companies
· FBRX · Pharmaceutical Preparations
Forte Biosciences, Inc. (FBRX)
Every material event, decoded in plain English — what each one means for the stock.
Aug 27, 2026
$2.2B acquisition
Forte Biosciences completes argenx’s $2.2B buyout as Nasdaq exit begins
Related companies in Pharmaceutical Preparations
ONC
ELAN
CMPS
UTHR
PRGO
ETON
QTTB
LLY
NAMS
RAPP
SMMT
RPRX
Open live on AllSight — the whole market, decoded →